MYRON ARLEN, MD
Medical Practice at Northern Blvd, Great Neck, NY
License number
New York 081218
Category
Medical Practice
Type
Specialist
Address
Address
600 Northern Blvd SUITE 111, Great Neck, NY 11021
Phone
(516) 487-9454
(516) 487-2745 (Fax)
(516) 487-2745 (Fax)
Organization information
See more information about MYRON ARLEN at bizstanding.comMyron Arlen MD
600 Northern Blvd, Great Neck, NY 11021
Industry:
Oncology, Surgeons
Site:
Phone:
(516) 487-9454 (Phone)
Myron Arlen
Professional information
Dr. Myron Arlen, Great Neck NY - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
North Shore University Hospital Sgcl ONC
600 Northern Blvd STE 111, Great Neck 11021
(516) 487-9454 (Phone)
600 Northern Blvd STE 111, Great Neck 11021
(516) 487-9454 (Phone)
Conditions:
Breast Cancer, Breast Lump/Mass, Carcinoma in Situ, Liver Cancer, Pancreatic Cancer
Certifications:
General Surgery, 1963
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
SUNY Downstate Medical Center College Of Medicine
Graduated: 1957
Jewish Hospital
Graduated: 1958
Graduated: 1962
Meml Hospital Sloan Kettering I
Graduated: 1965
Meml Sloan Kettering Cancer
SUNY Downstate Medical Center College Of Medicine
Graduated: 1957
Jewish Hospital
Graduated: 1958
Graduated: 1962
Meml Hospital Sloan Kettering I
Graduated: 1965
Meml Sloan Kettering Cancer
Myron Arlen, Great Neck NY
Specialties:
Surgeon
Address:
600 Northern Blvd, Great Neck, NY 11021
Education:
State University of New York Downstate Medical Center, College of Medicine - Doctor of Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Surgical Oncology
Interfaith Medical Center - Residency - Surgery
Memorial Sloan-Kettering Cancer Center - Fellowship - Surgical Oncology
Interfaith Medical Center - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Myron Arlen, Great Neck NY
Work:
North Shore Surgical Oncology
600 Northern Blvd, Great Neck, NY 11021
600 Northern Blvd, Great Neck, NY 11021
Identification And Development Of Specific Monoclonal Antibodies To Squamous Cell Carcinoma
US Patent:
7491801, Feb 17, 2009
Filed:
Aug 28, 2001
Appl. No.:
10/363095
Inventors:
Myron Arlen - Great Neck NY, US
Kwong Y. Tsang - Bethesda MD, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
International Bioimmune Systems, Inc. - Great Neck NY
International Classification:
C07K 16/00, C12P 21/08
US Classification:
5303871, 5303873, 5303881, 5303888
Abstract:
The present invention relates to novel antibodies, antibody fragments and antibody conjugates which display a high degree of selectivity for squamous cell carcinoma antigens including carcinomas of the lung, esophagus and cervix. The present invention relates to both in vivo and in vitro clinical screening methods for diagnosis or prognosis of carcinomas by means of detecting the expression of squamous cell carcinoma antigens in biological samples of the subject using the novel antibodies of the invention. The invention further provides for kits for carrying out the above described screening methods. Additionally, antibody conjugates may be used to efficiently deliver various agents which have anti-tumor effects to the tumor cell. The antibodies of the invention may also be administered to a patient in non-conjugated form to target ADCC to the tumor cell.
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers
US Patent:
7314622, Jan 1, 2008
Filed:
Apr 14, 2006
Appl. No.:
11/404566
Inventors:
Myron Arlen - Great Neck NY, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
Neogenix Oncology, Inc. - Rockville MD
International Classification:
A61K 39/00, A61K 39/395, G01N 33/574, C07K 16/00, C07H 21/04
US Classification:
4241551, 4241331, 4241381, 435 723, 5303883
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
Monoclonal Antibodies Against Human Colon Carcinoma-Associated Antigens And Uses Therefor
US Patent:
RE39760, Aug 7, 2007
Filed:
Aug 4, 2000
Appl. No.:
09/633034
Inventors:
Kwong Y. Tsang - Bethesda MD, US
Myron Arlen - Great Neck NY, US
Myron Arlen - Great Neck NY, US
Assignee:
International Bio-Immune Systems Inc. - Great Neck NY
International Classification:
G01N 33/574, G01N 33/53, C07K 16/30, C07K 16/18
US Classification:
435 723, 435 71, 435 72, 435 4051, 435 4052, 435325, 435328, 435329, 435330, 435332, 435344, 5303888, 5303871, 5303873, 5303875, 5303877, 5303881, 5303911, 5303913, 5303917
Abstract:
Monoclonal antibodies, in particular 33. 28 and 31. 1, and chimeric antibodies, in particular mouse/humans chimeric Chi #1 specific for glycoprotein antigens of colon carcinoma-associated antigens which are immunogenic in humans, are disclosed. Such antibodies, and fragments and derivatives thereof, are useful in immunodiagnosis and immunotherapy of human colon, breast, and ovarian cancer, and for purification of antigens which can serve as immunotherapeutic agents. Methods of detecting the colon carcinoma-associated antigen in a sample, and methods for treating subjects having colon, breast, and ovarian carcinomas are disclosed.
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers
US Patent:
2011015, Jun 30, 2011
Filed:
Jan 24, 2011
Appl. No.:
13/012679
Inventors:
Myron ARLEN - Great Neck NY, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
NEOGENIX ONCOLOGY, INC. - Rockville MD
International Classification:
A61K 51/00, C07K 16/18, C07K 17/00, A61K 39/395, A61K 38/19, A61P 35/00
US Classification:
424 111, 5303888, 5303873, 5303872, 5303917, 5303913, 4241561, 424 851
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.
Monoclonal Antibody Therapy For Pancreas Cancer
US Patent:
2006022, Oct 12, 2006
Filed:
Sep 22, 2005
Appl. No.:
11/234645
Inventors:
Myron Arlen - Great Neck NY, US
Kwong Tsang - Bethesda MD, US
Kwong Tsang - Bethesda MD, US
International Classification:
A61K 39/395, C07H 21/04, C12P 21/06, C07K 16/30
US Classification:
424155100, 536023530, 435069100, 435338000, 530388800, 435320100
Abstract:
The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.
Monoclonal Antibody Therapy For Pancreas Cancer
US Patent:
2011016, Jul 7, 2011
Filed:
Jan 21, 2011
Appl. No.:
13/011631
Inventors:
Myron ARLEN - Great Neck NY, US
Kwong TSANG - Bethesda MD, US
Kwong TSANG - Bethesda MD, US
Assignee:
NEOGENIX ONCOLOGY, INC. - Rockville MD
International Classification:
A61B 6/00, G01N 33/574, A61B 8/00
US Classification:
435 792, 436501, 435 71, 600407
Abstract:
The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers
US Patent:
8535667, Sep 17, 2013
Filed:
Jun 28, 2010
Appl. No.:
12/825022
Inventors:
Myron Arlen - Great Neck NY, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
J. Andrew Bristol - Bethesda MD, US
Ariel C. Hollinshead - Charlotte Harbor FL, US
Kwong Y. Tsang - Bethesda MD, US
Assignee:
Precision Biologics, Inc. - Dallas TX
International Classification:
A61K 39/395, C07K 16/18, G01N 33/53, A61P 35/00
US Classification:
4241331, 435 71, 5303873, 53038885, 5303913
Abstract:
The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.